We are live on ! Find out more
AGN

Allergan plc
AGN

Delisted

AGN was delisted on the 8th of May, 2020.

753 hedge funds and large institutions have $55.9B invested in Allergan plc in 2014 Q3 according to their latest regulatory filings, with 138 funds opening new positions, 374 increasing their positions, 189 reducing their positions, and 49 closing their positions.

New
Increased
Maintained
Reduced
Closed

182% more first-time investments, than exits

New positions opened: 138 | Existing positions closed: 49

98% more repeat investments, than reductions

Existing positions increased: 374 | Existing positions reduced: 189

96% more call options, than puts

Call options by funds: $1.97B | Put options by funds: $1B

41% more capital invested

Capital invested by funds: $39.7B → $55.9B (+$16.3B)

35% more funds holding in top 10

Funds holding in top 10: 84113 (+29)

12% more funds holding

Funds holding: 674753 (+79)

Holders
753
Holders Change
+79
Holders Change %
+11.72%
% of All Funds
21.84%
Holding in Top 10
113
Holding in Top 10 Change
+29
Holding in Top 10 Change %
+34.52%
% of All Funds
3.28%
New
138
Increased
374
Reduced
189
Closed
49
Calls
$1.97B
Puts
$1B
Net Calls
+$965M
Net Calls Change
+$483M
Name Holding Trade Value Shares
Change
Change in
Stake
Toronto Dominion Bank
551
Toronto Dominion Bank
Ontario, Canada
$1.2M -$671 -3 -0.1%
AIP
552
Ameritas Investment Partners
Nebraska
$1.18M +$322K +1,439 +42%
PAM
553
PartnerRe Asset Management
Connecticut
$1.17M -$177K -789 -14%
LWM
554
LBA Wealth Management
Florida
$1.16M +$11.2K +50 +1%
DCM
555
Dupont Capital Management
Delaware
$1.14M -$3.59M -16,042 -77%
MIG
556
Mariner Investment Group
New York
$1.13M +$1.05M +4,700 New
EFSCE
557
Enterprise Financial Services Corp (EFSC)
Missouri
$1.11M +$969K +4,332 +1,666%
MWR
558
McAdams Wright Ragen
Washington
$1.1M +$90.9K +406 +10%
SMG
559
Spectrum Management Group
Indiana
$1.1M +$27.8K +124 +3%
DC
560
Davenport & Co
Virginia
$1.1M -$23.5K -105 -2%
FPC
561
Falcon Point Capital
California
$1.09M -$351K -1,569 -26%
FB
562
Fulton Bank
Pennsylvania
$1.08M +$19.5K +87 +2%
Bank of Nova Scotia
563
Bank of Nova Scotia
Ontario, Canada
$1.06M +$375K +1,675 +61%
AC
564
Andromeda Capital
New York
$1.06M +$981K +4,384 New
LWA
565
Lenox Wealth Advisors
New York
$1.05M +$970K +4,334 New
KRSITF
566
Kentucky Retirement Systems Insurance Trust Fund
Kentucky
$1.04M +$27.1K +121 +2%
Cambridge Investment Research Advisors
567
Cambridge Investment Research Advisors
Iowa
$995K +$922K +4,122 New
Dodge & Cox
568
Dodge & Cox
California
$971K +$901K +4,025 New
AAP
569
Ardsley Advisory Partners
Connecticut
$965K +$224K +1,000 +33%
NBC
570
Neuberger Berman Canada
Ontario, Canada
$965K +$895K +4,000 New
BOTW
571
Bank of the West
California
$961K +$891K +3,982 New
Luther King Capital Management (LKCM)
572
Luther King Capital Management (LKCM)
Texas
$915K
BP
573
Banyan Partners
Florida
$906K +$840K +3,755 New
AWS
574
Aris Wealth Services
Pennsylvania
$899K +$13.2K +59 +2%
CONA
575
Capital One National Association
New York
$896K +$385K +1,722 +87%

AGN Hedge Fund Activity: Q3 2014 in Review

753 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q3 2014, worth a combined $55.9B — up 41% from $39.7B a quarter earlier.

Buyers outnumbered sellers: 138 funds opened new AGN positions and 49 closed out — a net gain of 89 holders — while 374 added to existing stakes and 189 trimmed.

The largest buyer was ClearBridge Investments, opening a new position worth an estimated $1.74B. The largest seller was AllianceBernstein, cutting an estimated $200M.

  • 753 institutional investors held Allergan plc (AGN) as of Q3 2014, up from 674 in Q2 2014.
  • Funds reported $55.9B of Allergan plc stock for Q3 2014, up 41% quarter-over-quarter.
  • 138 funds opened new Allergan plc positions in Q3 2014 and 49 closed out, a net change of +89 holders.
  • The largest Allergan plc buyer in Q3 2014 was ClearBridge Investments, an estimated $1.74B added.
  • The largest Allergan plc seller in Q3 2014 was AllianceBernstein, an estimated $200M sold.

Based on aggregated 13F filings for Q3 2014.